ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

NIH Seeking More Women, Minorities On Committees

November 9, 1979

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

June 25, 2004